Frequency and risk factors for hydroxychloroquine retinopathy among patients with systemic lupus erythematosus
{{output}}
Background: Hydroxychloroquine (HCQ) is an antimalarial drug, recently used in COVID-19 treatment. Also it is considered over many years the cornerstone in treating systemic lupus erythematosus (SLE) in adults and children. The i... ...
